Background: Prevalence, association and probable mode of acquisition of HBV and HIV dual infections have not been fully explored. Thus, HBV intervention plan and services are sometimes exclusively targeted towards HIV-infected population. We investigated HBV infection among HIV-infected cohort in comparison with HIV-negative hospital attendees to ascertain dual infectivity pattern; thereby encouraging appropriate allotment of intervention services. Materials and Methods: A total of 349 (M=141; F=208; Mean=33.98 years; Range= 0.33-80 years) plasma specimens from two virus diagnostic laboratories in south-western Nigeria were analysed. These include 182 HIV-positive and 167 HIV-negative specimens from ART and GDV laboratories respectively. The specimens were initially screened for detectable HIV antigen/antibody, and subsequently HBsAg by ELISA technique. Results: Overall, HBsAg was detected in 20.92% (95% CI: 16.65-25.19%) of the patients. Also, 24.82% (95% CI: 17.69-31.95%) and 18.27% (95% CI: 13.02-23.52%) HBsAg positivity was recorded for males and females respectively. CHI square analysis showed no association (P=0.14) between gender and prevalence of HBsAg. Similarly, comparison of prevalence of HBsAg by age groups shows no significant difference (P=0.24). Overall, no significant difference (P=0.59) was observed in the prevalence of HBsAg among the HIV-infected cohort and HIV-negative hospital attendees. Conclusions: Results of the study confirm endemicity and comparable rates of HBV infection independent of HIV-status.
Introduction
An estimated two billion people worldwide have serologic evidence of past or present Hepatitis B virus (HBV) infection and 360 million are both chronically infected and consequently at risk for HBV-related liver disease (WHO, 2000 (WHO, ., 2004 ., Wiersma et al., 2011) . HBV can be transmitted by transfusion of infected blood and through unsafe practices such as carrying out healthcare procedures with contaminated instruments (Norman, 1997; Mahoney 1999) . Also, perinatal and sexual exposures to HBV are highly efficient modes of transmission (Alter, 2006) .
Globally, 90% of human immunodeficiency virus (HIV)-infected persons has evidence of previous HBV infection, while 5 to 15% of total cases of HIV worldwide; that is, 2-4 million are estimated to have chronic HBV co-infection (Alter, 2006) . Such high prevalence has been attributed to routes of transmission shared by the two viruses. However, remarkable variation have been noted in the HIV-HBV dual infection rates depending largely on the geographic location, risk groups, the type of exposure involved and the socioeconomic condition of the particular region (Saha et al., 2011) .
Although, cases of Hepatitis B and HIV infections have been well documented in Nigeria (Iwalokun et al., 2006; Otegbayo et al., 2008; Adesina et al., 2010) .; prevalence, association and pattern of dual infectivity in the population have not been clearly defined. Thus, existing infrastructure and government-supported services appears to be largely directed toward HIV intervention with a notion that HBV infection is more prevalent among the group as reported in the developed countries. In that way, HBV may be spreading discreetly among untargeted population. Consequently, this study was designed to investigate prevalence of Hepatitis B infection among HIV-infected cohort in comparison with HIV-negative hospital attendees to ascertain rate of infection in both groups.
Materials and Methods

Study Area
Two virus diagnostic laboratories; General Diagnostic Virology (GDV) and Anti-Retroviral (ART) laboratories were selected for the study. GDV laboratory serves lying-in-ward and out-patient clinic attendees, as well as antiretroviral clinic referrals from different parts of the country, while the ART laboratory is designated for monitoring HIV-infected individuals on antiretroviral therapy. Both laboratories are attached to University Teaching Hospitals (UTH) in southwest region of Nigeria.
Study population
After obtaining ethical approval and informed consents, a total of 364 (182 specimens per site) blood specimens were obtained from the two selected diagnostic laboratories between September, 2010 and January, 2011. Demographic information of the selected specimens was recovered from the laboratory register. After preliminary HIV screening, a total of 15 plasma specimens with detectable HIV antigen/antibody from GDV laboratory were excluded from the study. Overall, a total of 349 {M=141; F=208; Mean age= 33.98 years [95% CI: 32.44-35.52 years]; Age range= 0.33-80 years} specimens were considered in the study analysis (Figure 1 ).
Sample collection, preparation and laboratory analysis
An average of 10 blood specimens was randomly selected from each laboratory per week. These specimens were recovered from the laboratory at the end of each week between September, 2010 and January, 2011. One hundred and eighty-two blood specimens were collected from each laboratory to accumulate a total of 364 specimens from the two centers. Whole blood specimens were treated for plasma extraction by centrifugation at 500 x g for 5 minutes. Thereafter, plasma specimens were stored at -20 o C until assayed. In strict compliance with the manufacturers' specifications, each plasma specimen was analyzed for the presence of HIV antigen and antibody using Genscreen Ultra HIV AgAb ELISA. Subsequently, a total of 349 (182 HIV-positive from ART and 167 HIV-negative from GDV) specimens were subjected to Hepatitis B surface antigen (HBsAg) using HBsAg one DIA.PRO  Diagnostic Bioprobes srl (Via Columella n o 31 20128 Milano-Italy) test kit. Thereafter, results were interpreted strictly as described by the test kit manufacturers.
Statistical analysis
Analysis was performed with SPSS version 15.0 for Windows (SPSS Inc., Chicago, IL.). Results were presented using descriptive statistics. Independent t-test was used to determine similarity in gender and mean ages of different age groups. CHI-square test was used to establish association between participants' variables, and prevalence of HBV and HIV-HBV dual infections. Indicator of statistical significance was set at p ≤ 0.05.
Results
Overall, age range of the studied patients is 0. 19 .3%, n=57; 31-37 years: 27.27%, n=33; and ≥ 38 years: 20.63%, n=63) among the four age groups showed no significant difference (P=0.76).
HBV and HIV-HBV dual positivity profiles among patients attending the ART laboratory
In ART laboratory, a total of 182 patients (age range: 0. In contrast to the report by Otegbayo et al., (2008) in a study involving HIV-infected cohort in south western Nigeria, statistical analysis showed no association (P=0.14) between gender and prevalence of HBV infection in this study. Also, no significant difference (P=0.24) was observed in the prevalence of HBV by age groups. However, prevalence of HIV by the same age groups showed high significant difference (P=0.001). This might be because all the patients in the ≤15yrs age group were HIV-positive and from the ART laboratory.
It is noteworthy that findings from this study are comparable with results of previous studies from different regions of the country 
Conclusions
Results of the study confirm endemicity and comparable prevalence of HBV infection among patients from the two study centers independent of their HIV status. This indicates that both study populations had comparable exposure to HBV. Therefore, HBV prevention measures should be promoted in the population regardless of HIV status. Also, existing infrastructure for government-supported HIV services should be expanded to include HBV education and management to reduce the spread of both infections. Nevertheless, due to higher morbidity and mortality in co-infected patients, providing the opportunity for HBV testing for HIV-infected people is essential.
